Major domestic drug firms to report 8-10% revenue growth in FY24: Icra

Leading domestic pharmaceutical companies in India are predicted to see an 8-10% increase in revenue in the current fiscal year, according to rating agency Icra. The agency expects this growth to continue into FY2024, supported by price increases, new product launches, and improved healthcare services in rural and semi-urban areas.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7YxEWkO
via IFTTT